All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Syndicated LoansInvestment Grade Loans

Shire snaffles Dyax for $5.9bn plus kicker for HAE drug

Pharmaceutical 230x150

Shire, the UK pharmaceutical company, has agreed to acquire US biopharmaceuticals company Dyax for $5.9bn in cash. Deutsche Bank and Morgan Stanley are arranging financing.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree